Description
Alcohol use disorders are common in community and clinical settings but often go unrecognised and untreated. Personality traits and dimensions are known to affect the development and maintenance of excessive alcohol consumption, but their influence has been somewhat overlooked in clinical practice. A range of pharmacological treatments are known to often be effective in relapse prevention, but clinicians are often unaware of their potential beneficial effects.
This mini-course is based on the Educational Update Session presented at the ECNP Congress in Milan, Italy,21-24 September 2024, making this highly regarded session accessible on-demand for everyone with a myECNP account.
Learning objectives
- Describe the neurobiological mechanisms underlying alcohol dependence.
- Analyse how neurobiology informs clinical innovations.
- Assess emerging pharmacological targets for alcohol use disorders.
Audience
The mini-course series is designed for clinicians and clinical researchers, providing the latest insights into evidence-based clinical practice.
Course format
The mini-course series are based on the Educational Update Sessions presented at the ECNP Congress in Milan, 21-24 September 2024. They consist of two 30-minute lectures, incorporating interactive knowledge checks during the lectures.
Course schedule
Lecture 1.1 - The neurobiology of alcohol dependence (Anne Lingford-Hughes)
Lecture 1.2 - Novel mechanisms and targets for pharmacotherapy in alcohol use disorders (Markus Heilig)
How to enrol
This course is freely accessible to all individuals with a myECNP account. If you do not yet have a myECNP account, please visit the ECNP website at ecnp.eu and navigate to the ‘myECNP’ tab.
Registration is open now.
Should you have any questions, please feel free to contact us at courses@ecnp.eu.